Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 4, 1998, Pages 913-916

  Shibata, Toru ^a   Akiyama, Nobutake ^b   Noda, Makoto ^b   Sasai, Keisuke ^a   Hiraoka, Masahiro ^a  

^a Sakyo ku ^*  (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Erythropoietin; Hypoxia; Hypoxia responsive element; Hypoxia inducible factor 1; Vascular endothelial growth factor

Indexed keywords

ERYTHROPOIETIN; VASCULOTROPIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; GENE EXPRESSION; GENE THERAPY; HYPOXIA; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL HYPOXIA; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; ERYTHROPOIETIN; GENE EXPRESSION; GENETIC VECTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUCIFERASES; LYMPHOKINES; MICE; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031742542     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00298-3     Document Type: Conference Paper

References (20)

1. Goldberg M.A., Glass G.A., Cunningham J.M., Bunn H.F. The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci. 84:1987;7972-7976.
2. Semenza G.L., Nejfelt M.K., Chi S.M., Antonarakis S.E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci. 88:1991;5680-5684.
3. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
4. Beck I., Ramirez S., Weinmann R., Caro J. Enhancer element at the 3'-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J Biol Chem. 266:1991;15563-15566.
5. Madan A., Curtin P.T. A 24-base-pair sequence 3' to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc Natl Acad Sci. 90:1993;3928-3932.
6. Goldberg M.A., Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem. 269:1994;4355-4359.
7. Dachs G.U., Patterson A.V., Firth J.D., Ratcliffe P.J., Townsend K.M., Stratford I.J., Harris A.L. Targeting gene expression to hypoxic tumor cells. Nat Med. 3:1997;515-520.
8. Mazure N.M., Chen E.Y., Yeh P., Laderoute K.R., Giaccia A.J. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56:1996;3436-3440.
9. Beck I., Weinmann R., Caro J. Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood. 82:1993;704-711.
10. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res. 77:1995;638-643.
11. Noda M., Kitayama H., Matsuzaki T., Sugimoto Y., Okayama H., Bassin R.H., Ikawa Y. Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc Natl Acad Sci. 86:1989;162-166.
12. Setoguchi Y., Danel C., Crystal R.G. Stimulation of erythropoiesis by in vivo gene therapy physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vector . Blood. 84:1994;2946-2953.
13. Pugh C.W., Tan C.C., Jones R.W., Ratcliffe P.J. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene. Proc Natl Acad Sci. 88:1991;10553-10557.
14. Semenza G.L., Koury S.T., Nejfelt M.K., Gearhart J.D., Antonarakis S.E. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci. 88:1991;8725-8729.
15. Kieser A., Weich H.A., Brandner G., Marme D., Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene. 9:1994;963-969.
16. Grugel S., Finkenzeller G., Weindel K., Barleon B., Marme D. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem. 270:1995;25915-25919.
17. Mukhopadhyay D., Tsiokas L., Zhou X.M., Foster D., Brugge J.S., Sukhatme V.P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 375:1995;577-581.
18. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 16:1996;4604-4613.
19. Levy A.P., Levy N.S., Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem. 271:1996;2746-2753.
20. Damert A., Machein M., Breier G., Fujita M.Q., Hanahan D., Risau W., Plate K.H. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res. 57:1997;3860-3864.